These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 1356617

  • 1. Cyclophosphamide resistance in medulloblastoma.
    Friedman HS, Colvin OM, Kaufmann SH, Ludeman SM, Bullock N, Bigner DD, Griffith OW.
    Cancer Res; 1992 Oct 01; 52(19):5373-8. PubMed ID: 1356617
    [Abstract] [Full Text] [Related]

  • 2. Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines.
    Peters RH, Jollow DJ, Stuart RK.
    Cancer Res; 1991 May 15; 51(10):2536-41. PubMed ID: 2021933
    [Abstract] [Full Text] [Related]

  • 3. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
    Evans CG, Bodell WJ, Tokuda K, Doane-Setzer P, Smith MT.
    Cancer Res; 1987 May 15; 47(10):2525-30. PubMed ID: 2882834
    [Abstract] [Full Text] [Related]

  • 4. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 15; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 5. Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.
    Lau DH, Lewis AD, Ehsan MN, Sikic BI.
    Cancer Res; 1991 Oct 01; 51(19):5181-7. PubMed ID: 1717140
    [Abstract] [Full Text] [Related]

  • 6. Melphalan transport, glutathione levels, and glutathione-S-transferase activity in human medulloblastoma.
    Friedman HS, Skapek SX, Colvin OM, Elion GB, Blum MR, Savina PM, Hilton J, Schold SC, Kurtzberg J, Bigner DD.
    Cancer Res; 1988 Oct 01; 48(19):5397-402. PubMed ID: 3416297
    [Abstract] [Full Text] [Related]

  • 7. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP, Downes HF, Mirski SE, Clements DJ.
    Mol Pharmacol; 1990 Feb 01; 37(2):192-7. PubMed ID: 1968221
    [Abstract] [Full Text] [Related]

  • 8. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 9. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
    Bacolod MD, Lin SM, Johnson SP, Bullock NS, Colvin M, Bigner DD, Friedman HS.
    Curr Cancer Drug Targets; 2008 May 01; 8(3):172-9. PubMed ID: 18473730
    [Abstract] [Full Text] [Related]

  • 10. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY, Teicher BA, Shea TC, Holden SA, Rosbe KW, al-Achi A, Henner WD.
    Cancer Res; 1989 Nov 15; 49(22):6185-92. PubMed ID: 2804968
    [Abstract] [Full Text] [Related]

  • 11. Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.
    Crook TR, Souhami RL, Whyman GD, McLean AE.
    Cancer Res; 1986 Oct 15; 46(10):5035-8. PubMed ID: 3463410
    [Abstract] [Full Text] [Related]

  • 12. Identification of glutathione S-transferase as a determinant of 4-hydroperoxycyclophosphamide resistance in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1995 May 26; 49(11):1691-701. PubMed ID: 7786310
    [Abstract] [Full Text] [Related]

  • 13. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.
    Dong Q, Bullock N, Ali-Osman F, Colvin OM, Bigner DD, Friedman HS.
    Cancer Chemother Pharmacol; 1996 May 26; 37(3):242-46. PubMed ID: 8529284
    [Abstract] [Full Text] [Related]

  • 14. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
    Berger SJ, Gosky D, Zborowska E, Willson JK, Berger NA.
    Cancer Res; 1994 Aug 01; 54(15):4077-83. PubMed ID: 8033140
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.
    Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF.
    Cancer Res; 1984 Nov 01; 44(11):5427-31. PubMed ID: 6488194
    [Abstract] [Full Text] [Related]

  • 16. Glutathione depletion by L-buthionine sulfoximine antagonizes taxol cytotoxicity.
    Liebmann JE, Hahn SM, Cook JA, Lipschultz C, Mitchell JB, Kaufman DC.
    Cancer Res; 1993 May 01; 53(9):2066-70. PubMed ID: 8097674
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
    Oguchi H, Kikkawa F, Kojima M, Maeda O, Mizuno K, Suganuma N, Kawai M, Tomoda Y.
    Anticancer Res; 1994 May 01; 14(1A):193-200. PubMed ID: 7909418
    [Abstract] [Full Text] [Related]

  • 19. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J, Astor MB, Taub RN, Baker MA, Bhalla K, Gervasoni JE, Rosado M, Stewart V, Krishna S, Hindenburg AA.
    Cancer Res; 1989 Aug 01; 49(15):4120-5. PubMed ID: 2568167
    [Abstract] [Full Text] [Related]

  • 20. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
    Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM.
    Cancer Chemother Pharmacol; 1999 Aug 01; 43(1):80-5. PubMed ID: 9923545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.